References
- Pitukkijronnakorn S, Promsonthi P, Panburana P, Udomsubpayakul U, Chittacharoen A. Fetal loss associated with second trimester amniocentesis. Arch Gynecol Obstet 2011;284:793–797.
- Mademont-Soler I, Morales C, Clusellas N, Soler A, Sánchez A; Group of Cytogenetics from Hospital Clínic de Barcelona. Prenatal cytogenetic diagnosis in Spain: analysis and evaluation of the results obtained from amniotic fluid samples during the last decade. Eur J Obstet Gynecol Reprod Biol 2011;157:156–160.
- Park IY, Kwon JY, Kim YH, Kim M, Shin JC. Maternal age-specific rates of fetal chromosomal abnormalities at 16-20 weeks’ gestation in Korean pregnant women >or=35 years of age. Fetal Diagn Ther 2010;27:214–221.
- Kazerouni NN, Currier B, Malm L, Riggle S, Hodgkinson C, Smith S, Tempelis C, et al. Triple-marker prenatal screening program for chromosomal defects. Obstet Gynecol 2009;114:50–58.
- Offerdal K, Blaas HG, Eik-Nes SH. Prenatal detection of trisomy 21 by second-trimester ultrasound examination and maternal age in a non-selected population of 49 314 births in Norway. Ultrasound Obstet Gynecol 2008;32:493–500.
- Tseng JJ, Chou MM, Lo FC, Lai HY, Chen MH, Ho ES. Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995-2004. Taiwan J Obstet Gynecol 2006;45:39–41.
- Kagan KO, Chitty LS, Cicero S, Eleftheriades M, Nicolaides KH. Ultrasound findings before amniocentesis in selecting the method of analysing the sample. Prenat Diagn 2007;27:34–39.
- Hecht CA, Hook EB. The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening. Prenat Diagn 1994;14:729–738.
- Langlois S, Duncan A. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies. J Obstet Gynaecol Can 2011;33:955–960.
- ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217–227.
- Dailey T, Dale B, Cohen J, Munné S. Association between nondisjunction and maternal age in meiosis-II human oocytes. Am J Hum Genet 1996;59:176–184.
- Savva GM, Morris JK, Mutton DE, Alberman E. Maternal age-specific fetal loss rates in Down syndrome pregnancies. Prenat Diagn 2006;26:499–504.
- Druzin ML, Chervenak F, McCullough LB, Blatman RN, Neidich JA. Should all pregnant patients be offered prenatal diagnosis regardless of age? Obstet Gynecol 1993;81:615–618.
- Ghosh S, Feingold E, Dey SK. Etiology of Down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations. Am J Med Genet A 2009;149A:1415–1420.
- Driscoll DA, Morgan MA, Schulkin J. Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 2009;200:459.e1–459.e9.
- Maulik D. New directions in prenatal care. J Matern Fetal Neonatal Med 2003;13:361.
- Cuckle HS. Growing complexity in the choice of Down’s syndrome screening policy. Ultrasound Obstet Gynecol 2002;19:323–326.
- Breathnach FM, Malone FD. Screening for aneuploidy in first and second trimesters: is there an optimal paradigm? Curr Opin Obstet Gynecol 2007;19:176–182.
- Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221–226.
- Nyberg DA, Souter VL, El-Bastawissi A, Young S, Luthhardt F, Luthy DA. Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. J Ultrasound Med 2001;20:1053–1063.
- Benn PA, Fang M, Egan JF. Trends in the use of second trimester maternal serum screening from 1991 to 2003. Genet Med 2005;7:328–331.
- Rozenberg P, Bussières L, Chevret S, Bernard JP, Malagrida L, Cuckle H, Chabry C, et al. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol 2006;195:1379–1387.
- Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in perspective. BJOG 2004;111:521–531.
- Dommergues M, Audibert F, Benattar C, Champagne C, Gomel V, Frydman R. Is routine amniocentesis for advanced maternal age still indicated? Fetal Diagn Ther 2001;16:372–377.
- Hartnett J, Borgida AF, Benn PA, Feldman DM, DeRoche ME, Egan JF. Cost analysis of Down syndrome screening in advanced maternal age. J Matern Fetal Neonatal Med 2003;13:80–84.
- Lau TK, Jiang F, Chan MK, Zhang H, Salome Lo PS, Wang W. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 2012 Oct 4. [Epub ahead of print].
- Lau TK, Chan MK, Salome Lo PS, Connie Chan HY, Kim Chan WS, Koo TY, Joyce Ng HY, Pooh RK. Clinical utility of noninvasive fetal trisomy (NIFTY) test - early experience. J Matern Fetal Neonatal Med 2012.
- Clerici G, Donti E, Zacutti A, Di Renzo GC. Prenatal diagnosis in Italy. Eur J Hum Genet 1997;5 Suppl 1:42–47.